BIOLASE (NASDAQ:BIOL) Coverage Initiated at StockNews.com

Stock analysts at StockNews.com started coverage on shares of BIOLASE (NASDAQ:BIOL) in a note issued to investors on Tuesday. The brokerage set a “sell” rating on the medical technology company’s stock.

BIOLASE Price Performance

Shares of NASDAQ:BIOL opened at $0.01 on Tuesday. The company has a market capitalization of $267,256.00, a PE ratio of 0.00 and a beta of 0.67. The business has a fifty day moving average price of $0.01 and a two-hundred day moving average price of $0.02. BIOLASE has a 1 year low of $0.02 and a 1 year high of $1.94.

BIOLASE Company Profile

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.